Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.56B | ― | ― | ― | ― | ― | Gross Profit |
3.07B | 3.73B | 3.59B | 3.36B | 3.01B | 2.61B | EBIT |
1.15B | 1.21B | 1.13B | 987.40M | 812.80M | 539.40M | EBITDA |
1.64B | 1.36B | 1.32B | 1.44B | 1.18B | 2.04B | Net Income Common Stockholders |
889.30M | 832.90M | 865.80M | 755.20M | 608.40M | 1.61B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
― | ― | ― | ― | ― | ― | Total Assets |
17.02B | 17.02B | 16.91B | 15.89B | 16.47B | 16.05B | Total Debt |
3.71B | 3.71B | 3.65B | 3.25B | 4.14B | 4.43B | Net Debt |
2.89B | 2.89B | 1.76B | 2.54B | 3.32B | 1.49B | Total Liabilities |
6.82B | 6.82B | 6.59B | 6.20B | 6.95B | 7.08B | Stockholders Equity |
― | ― | ― | ― | ― | ― |
Cash Flow | Free Cash Flow | ||||
1.35B | 1.47B | 1.35B | 1.21B | 915.60M | 1.37B | Operating Cash Flow |
1.47B | 1.53B | 1.35B | 1.30B | 961.10M | 1.44B | Investing Cash Flow |
-1.87B | ― | ― | ― | ― | ― | Financing Cash Flow |
501.90M | ― | ― | ― | ― | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $76.96B | 22.39 | 105.16% | 2.21% | -1.30% | 20.26% | |
75 Outperform | $26.27B | 32.71 | 8.17% | 0.41% | 2.75% | -2.90% | |
72 Outperform | $42.29B | 30.93 | 14.25% | 0.60% | 5.22% | 4.46% | |
68 Neutral | $135.18B | 23.89 | 596.13% | 2.08% | 5.05% | 2.73% | |
66 Neutral | $31.51B | 34.67 | 27.22% | 1.84% | -11.28% | -23.69% | |
65 Neutral | $147.01B | 38.89 | 7.87% | 0.53% | -13.50% | -17.25% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |
On February 26, 2025, Fortive Corporation expanded its Board of Directors from nine to ten members, appointing Gregory J. Moore, M.D., Ph.D., as a new board member. Dr. Moore will also serve on the Compensation Committee and Nominating and Governance Committee, receiving the same compensation as other non-employee directors. His appointment highlights Fortive’s commitment to strengthening its governance and leadership structure, with Dr. Moore being recognized as an independent director under NYSE standards.
On January 28, 2025, Alan G. Spoon informed Fortive Corporation’s Board of Directors that he will not seek re-election and will retire effective June 3, 2025. His decision was not due to any disagreement with the company. Consequently, the board will reduce its size from nine to eight members and has appointed Sharmistha Dubey as the new Chair of the Board.
Fortive Corporation has advised its shareholders to reject an unsolicited mini-tender offer from TRC Capital Investment Corporation, which seeks to purchase 1,500,000 shares at a price below the current market value. The company emphasizes that these offers often bypass investor protections and urges shareholders to exercise caution, referencing similar past offers by TRC and the SEC’s warnings about mini-tender offers. Fortive recommends shareholders to withdraw any shares already tendered to TRC and consult with financial advisors.